Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease
Condition(s):Neuropsychiatric Symptoms Related to Neurodegenerative DiseaseLast Updated:February 2, 2024Completed
Hide Studies Not Open or Pending
Condition(s):Neuropsychiatric Symptoms Related to Neurodegenerative DiseaseLast Updated:February 2, 2024Completed
Condition(s):SchizophreniaLast Updated:August 18, 2023Recruiting
Condition(s):Parkinson’s Disease PsychosisLast Updated:February 9, 2024Recruiting
Condition(s):Autism Spectrum DisorderLast Updated:February 6, 2024Not yet recruiting
Condition(s):Alzheimer’s Disease PsychosisLast Updated:October 25, 2017Completed
Condition(s):Treatment of Depression in Adults With Parkinson’s Disease (PD)Last Updated:August 31, 2020Completed
Condition(s):Agitation and Aggression in Alzheimer’s DiseaseLast Updated:April 9, 2020Completed
Condition(s):Parkinson’s Disease PsychosisLast Updated:October 5, 2023Recruiting
Condition(s):Adjunctive Treatment of Major Depressive DisorderLast Updated:November 17, 2021Completed
Condition(s):SchizophreniaLast Updated:August 16, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.